BIC (BB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 organic net sales grew by 1.6%, meeting expectations, with broad-based gains across categories and regions, except for declines in the Middle East and Africa due to ongoing conflict.
US performance improved, led by Stationery and Lighters, while Tangle Teezer delivered 13% organic growth with double-digit gains in North America and Europe.
Portfolio streamlined by exiting underperforming businesses, with new leadership fully operational and a strategic plan to be announced in September 2026.
Financial highlights
Q1 2026 net sales were €453m, up 1.6% organically year-over-year, but down 5.3% reported due to negative FX (-5.0%) and perimeter (-1.9%) impacts.
Stationery contributed €4m, lighters €3m, and Blade Excellence €1m to organic growth.
All divisions posted organic growth: Human Expression +3.0%, Flame for Life +1.7%, Blade Excellence +0.6%.
Latin America led regional organic growth at +5.3%; North America and Europe both grew +1.6% organically.
Volume declined by 1%, while price/mix was positive across all markets.
Outlook and guidance
2026 outlook remains unchanged: improving organic net sales trends, slight expansion in adjusted EBIT margin, and stable free cash flow year-over-year.
Cautious stance maintained due to ongoing volatility, especially in the Middle East.
Full strategy update to be presented in September; focus remains on delivering commitments and sustainable growth.
Latest events from BIC
- H1 2026 delivered organic growth, margin gains, strong cash flow, and an upgraded outlook.BB
Q2 2026 - All resolutions passed as the company pivots to new strategy, governance, and sustainability priorities.BB
AGM 2026 - Resilient 2025 performance, strong cash flow, and renewed growth in Q1 2026.BB
Investor presentation - 2024 sales hit €2.2bn, with strong margins, cash flow, and leadership in core categories.BB
Investor presentation - Net sales fell 0.9% to €2,090m, but Free Cash Flow and Tangle Teezer growth remained strong.BB
Q4 2025 - Q3 2024 saw robust margin gains and cash flow, with an upgraded EBIT margin outlook.BB
Q3 2024 - Resilient margins and growth outside North America support 2024 outlook and cash flow.BB
Q2 2024 - Q1 2025 sales fell 8.3% as reported; 2025 outlook cut to 0–3% growth, 15% EBIT margin.BB
Q1 2025 - Resilient 2024 results with strong margins and Tangle Teezer set to drive 2025 growth.BB
Q4 2024